The FTSE 100 ended a difficult week firmly in negative territory on Friday, dragged lower by surging oil prices and growing unease over artificial intelligence investment returns. The blue-chip index closed down
US equity markets closed in negative territory as investors balanced a mixed set of economic signals against growing geopolitical uncertainty in the Middle East. The S&P 500 index ended the session lower,
More
Alfasigma has announced plans to acquire Nordic Pharma from Sever Life Sciences in a deal worth an undisclosed sum, marking its latest international expansion move. The Italian drugmaker is purchasing Nordic Pharma,
More
A Florida federal court has allowed a claim under the Florida Telephone Solicitation Act to proceed, despite the defendant’s assertion that an established business relationship barred the lawsuit. The case, Specht v.
More
The American Bar Association is preparing a significant restructuring of its organisational structure as it grapples with mounting financial pressures and declining revenue. The organisation is on track to see its revenue
More
Coca-Cola FEMSA (NYSE: KOF) has had its fair value estimate modestly reduced by analysts, who are taking a more cautious stance on the company’s near-term growth prospects. The Mexican bottling giant, which
More
The global pharmaceutical cold chain market faces mounting pressure as high-value, temperature-sensitive medications become an increasingly significant share of drug pipelines worldwide. Biologics, vaccines, and cell and gene therapies require strict temperature
More
On 13 August 2026, the Department of Justice’s newly created National Fraud Enforcement Division published a memorandum outlining its core enforcement priorities for the months ahead. Colin M. McDonald, Assistant Attorney General
More
The US Department of Justice has reached an interstate stalking plea deal with Luigi Mangione, a move widely seen as a deliberate effort to complicate New York’s murder case. By securing a
More
London’s FTSE 100 index edged lower during a subdued trading session, reflecting broader uncertainty across European financial markets on the day. Investors across the continent faced a choppy trading environment, with major
More
A federal appeals court has overturned the 2024 dismissal of a lawsuit accusing Bristol Myers Squibb of deliberately delaying approval of blood cancer drug Breyanzi. The U.S. Circuit Court of Appeals in
More